Showing results (381-390 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|March 4, 2016
Psychiatric side effects of acute high-dose corticosteroid therapy in neurological conditionsItay Lotan, Liora Fireman, Felix Benninger, et al.International Clinical Psychopharmacology|August 1, 2015
Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysisAnita H Clayton, Eunhee Hwang, Susan G Kornstein, et al.International Clinical Psychopharmacology|December 9, 2014
Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012)María V Balda, Osvaldo U Garay, Rosa M Papale, et al.International Clinical Psychopharmacology|December 16, 2014
Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trialShadi Asadollahi, Kamran Heidari, Hamidreza Hatamabadi, et al.International Clinical Psychopharmacology|December 2, 2014
Predictors of placebo response in bipolar depressionAndrew A Nierenberg, Søren D Østergaard, Nadia Iovieno, et al.International Clinical Psychopharmacology|January 1, 1989
Efficacy, safety and tolerability of raclopride, a specific D2 receptor blocker, in acute schizophrenia: an open trialJ C Cookson, B Natorf, N Hunt, et al.International Clinical Psychopharmacology|July 1, 1987
A double-blind placebo controlled trial of a selective beta 2 adrenoceptor antagonist (ICI 118551) in chronic anxietyD J King, N M Devaney, J K GilbertInternational Clinical Psychopharmacology|February 15, 2020
Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trialLakshmi N Yatham, Eduard Vieta, Willie EarleyInternational Clinical Psychopharmacology|February 22, 2020
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatmentChiara Fabbri, Stuart Montgomery, Cathryn M Lewis, et al.International Clinical Psychopharmacology|December 17, 2014
Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescentsLucia Margari, Emilia Matera, Maria G Petruzzelli, et al.Pageof 212